Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation
Which stocks are undervalued right now? Check free
Discover now →
Sicagen India Limited (533014) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Sicagen India Limited ₹92.58, price ₹51.45, upside +79.9%, quality 62 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? Yes
- Good quality? Yes
- Add to watchlist
SI
Thin data
Oct 2, 2026
Sicagen India Limited
533014 · BSEClearly undervaluedStrong Fair Value upside, but quality is only moderate.
✓Fair value ₹92.58 · Strongly undervalued (+79.9%)
✓Quality 62/100
✓Healthy Growth (revenue 5y +12.4 %/yr)
!Loss over the last twelve months · -0.4% net margin (TTM) · fiscal year 2026 1.9%
✓Low debt · generates free cash flow
✓1.9% dividend yield · Sustainable
!Narrow moat 11/100
!Evidence only low, so the estimate is less certain
Watch Sicagen India Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.
Watch for free
Pro now: $1 first month
What runs behind every stock
26
valuation models
8 families, DCF to NCAV
37
quality factors
margins, balance sheet, cashflow, debt
6
AI factors
moat, what no ratio measures
2,000+
data points
verified, per stock, median
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 2, 2026.
How to read this chart
60‑month range ₹18.51 – ₹111.28 · fair‑value band ₹61.97 – ₹119.87 · the ₹51.45 price screens below the ₹92.58 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 2, 2026.
Company profile
Sicagen India Limited trades in and distributes building materials in India and internationally. It operates through Trading and Manufacturing segments.
Show more
Sicagen India Limited trades in and distributes building materials in India and internationally. It operates through Trading and Manufacturing segments. The company offers building materials, such as MS/GI pipes, precision tubes, structural tubes, seamless tubes, ERW tubes, rectangular/square hollow sections, steel fittings, PVC pipes, UPVC pipes, roofing sheets, electrical cables, switchgears, cement, etc., as well as construction steel, including TMT steel rebars. It also provides mechanical governor services, servicing for actuators, field services, and conversion of mechanical and electronic governing systems; and manufactures drums and barrels that are used for the transport of lubricant oil, hazardous and non-hazardous chemicals, bitumen, and fruit pulp. In addition, the company offers water treatment and process enhancement solutions for petrochemical, fertilizer, refinery, power, pharmaceutical, agro, and pesticide industries; builds boats, tugs, and barges; manufactures cables for industrial and other critical applications; and engages in the precision fabrication of steel, carbon steel, mild steel, and aluminum. It serves dealers, contractors, builders, and corporate buyers. The company was incorporated in 2004 and is based in Chennai, India.
Stock analysis
Sicagen India Limited (533014) currently trades at ₹51.45, while our model-based Fair Value estimate is ₹92.58, implying the stock looks roughly 44.4% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of ₹146.60 per share, and 22 of the 26 models we run sit above the ₹51.45 price.
Bear case: the Dividend Discount group reads lowest at ₹13.97, and 4 of the 26 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹61.97 (bear) to ₹119.87 (bull), the price of ₹51.45 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 62/100 (solid quality), in the Industrial Goods sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Sicagen India Limited reported revenue of ₹9.7B in FY2026 versus ₹8.4B in FY2022, a compound +3.9%/yr. Reported net income was ₹181M in FY2026.
Key figures
Market cap ₹434M (≈ $4.5M) · P/E ratio 12.8 · P/S ratio 0.24 · EPS (TTM) ₹1.09 · Dividend yield 1.9% · Net margin 1.9% · Return on assets (EBIT) 3.1% · Operating margin −0.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 26% below its 52-week high and 20% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrial Goods peers we cover trades at −37% fair-value upside, at 80%, 533014 screens cheaper than that median.
Fair Value models
Bear ₹61.97
Fair Value ₹92.58
Bull ₹119.87
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹0.0459 per share) are deliberately not added.
Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.
Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF
₹138.74
₹205.15
₹301.08
80
Growth DCF
₹140.89
₹199.84
₹280.03
79
Owner Earnings
₹97.50
₹143.23
₹209.29
76
All 26 models by family
DCF Models
FCF DCF
₹138.74
₹205.15
₹301.08
80
Owner Earnings
₹97.50
₹143.23
₹209.29
76
5Y Revenue Exit
₹94.12
₹133.17
₹181.21
73
5Y EBITDA Exit
₹109.09
₹160.90
₹219.75
75
5Y P/E Exit
₹95.07
₹134.94
₹175.49
71
10Y Revenue Exit
₹107.82
₹146.60
₹195.56
67
10Y EBITDA Exit
₹119.01
₹165.32
₹224.04
69
10Y P/E Exit
₹110.30
₹147.80
₹191.33
65
Earnings-Based
Graham-Dodd
₹31.05
₹91.89
₹121.58
65
Lynch FV
₹19.31
₹27.58
₹35.86
61
PEG = 1.0
₹19.31
₹27.58
₹35.86
57
EPV
₹64.77
₹74.01
₹81.97
74
Dividend Discount
Gordon GGM
₹8.79
₹17.51
₹26.52
67
DDM Multi-Stage
₹8.79
₹13.97
₹18.49
66
Multiples
P/E Multiple
₹71.92
₹95.89
₹119.87
63
P/S Multiple
₹58.22
₹77.63
₹97.04
58
P/B Multiple
₹58.22
₹77.63
₹97.04
55
EV/EBIT
₹98.13
₹128.74
₹159.35
66
EV/EBITDA
₹103.14
₹135.41
₹167.69
67
EV/Revenue
₹71.85
₹99.94
₹128.02
54
Asset-Based
NCAV (Graham)
₹62.55
₹83.81
₹125.09
54
Growth DCF
Growth DCF
₹140.89
₹199.84
₹280.03
79
Rev-Margin DCF
₹94.12
₹134.75
₹181.43
73
Economic Profit
Residual Income
₹90.93
₹88.35
₹90.47
76
ROIC Compounder
₹64.77
₹74.01
₹81.97
72
Growth Earnings
Growth-Adj P/E
₹58.46
₹83.51
₹108.56
67
Notify me when 533014 reaches fair value
Put 533014 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Overall quality
62/100
Of which business quality 64 · Market factors (momentum, volatility) 28
Profitability
40
Margins and returns on capital today
Quality Growth
61
Are margins and returns improving?
Cashflow
60
Earnings quality: real cash, not paper profit
Fin. Strength
71
Balance sheet, leverage, solvency risk
Investment
84
Disciplined investing over empire-building
Low Volatility
43
Calm price path (market factor)
Momentum
27
Price trend over the last 3–12 months (market factor)
52W Momentum
13
Distance to the 52-week high (market factor)
Net Issuance
82
Share count: buybacks or dilution?
Revenue & earnings trend
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.
82/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+9.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.4%
Start year 2021 (pandemic). Over 10 years: +4.9% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.8%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 3 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+10.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+8.4%
Dividend (yield on the price)1.9%
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.0% → 3%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−5.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about −9.6% a year for the price.
Watch 533014, get fair value alerts →
Compare Sicagen India Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “General Building Materials” was too small, so the broader sector is used.)Industrials · 5313 stocks
Beats the sector median on 4/8 measures
A mixed picture versus its sector peers.
Valuation Multiplesvs Industrials median · lower = cheaper
Context: sector, industry, market
- Is the Industrials sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: Industrials
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more General Building Materials stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Pacific Industries Limited 523483 | ₹136.20 | ₹120.90 | −11% |
| Keerthi Industries Limited 518011 | ₹41.34 | ₹21.42 | −48% |
| Inani Marbles and Industries Limited 531129 | ₹10.50 | ₹12.94 | +23% |
| SOLIDSTON SOLIDSTON | ₹25.86 | ₹31.87 | +23% |
| Ecoboard Industries Limited 523732 | ₹61.79 | ₹8.48 | −86% |
| Raymond Limited 500330 | ₹1,199 | ₹350.92 | −71% |
| FRONTSP FRONTSP | ₹1,417 | ₹889.77 | −37% |
| DISAQ DISAQ | ₹11,343 | ₹4,347 | −62% |
| BATLIBOI BATLIBOI | ₹82.38 | ₹24.39 | −70% |
| FLUIDOM FLUIDOM | ₹720.75 | ₹792.83 | +10% |
Explore undervalued stocks
All undervalued stocks
TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
🥇 Backtested Best
🏆 Big Names
⭐ Top Rated
💎 Quality on Sale
🚀 Profitable Growth
🧊 Quality Compounders
💵 Dividend Stars
📈 Strong Momentum
📉 Fallen Angels
⚖️ Deeply Undervalued
🔍 Small-Cap Gems
🏰 Moat at a Fair Price
💼 Insider Buying
🎩 Buffett-Style Quality
📚 Peter Lynch GARP
🧮 Greenblatt Magic Formula
🛡️ Graham Defensive
Discover tools
Stock screenerFilter by region, size and sector
Compare toolTwo stocks side by side
Extrinsic Value Calculator…Calculator with industry benchmark
Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
Frequently asked questions
Is Sicagen India Limited (533014) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of ₹92.58 versus a price of ₹51.45, about +80% upside (undervalued).
What is the fair value of 533014?
Our model-based fair value for Sicagen India Limited is ₹92.58 (as of Oct 2, 2026), built from audited fundamentals. The current price: ₹51.45.
What is the quality score of 533014?
Sicagen India Limited has a Quality Score of 62/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sicagen India Limited (533014)?
Our model-based price target is the fair value of ₹92.58 (as of Oct 2, 2026) from 26 valuation models. Cautious scenario ₹61.97, optimistic scenario ₹119.87. It is a calculation from audited fundamentals, not an analyst target.
What is the Sicagen India Limited stock forecast for 2026?
Our models put fair value at ₹92.58, about +80% upside versus a price of ₹51.45 (undervalued). Cautious scenario ₹61.97, optimistic scenario ₹119.87. The calculation is refreshed regularly with new filings.
What is the revenue of Sicagen India Limited (533014)?
Sicagen India Limited reported trailing-twelve-month revenue of about ₹5.9B (latest available figure, as of Oct 2, 2026).
Does Sicagen India Limited pay a dividend?
Sicagen India Limited currently shows a dividend yield of about 1.94% relative to its recent price (as of Oct 2, 2026).
What growth is priced into Sicagen India Limited (533014)?
For today's price to be fair in a discounted-cash-flow model, Sicagen India Limited would have to grow free cash flow by -5.8 % per year for five years (discount rate 12.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +12.4 % per year. As of Oct 2, 2026.
What discount rate (WACC) does the fair value of 533014 use?
Our models discount Sicagen India Limited at 12.4 %: a base by market capitalisation (nano), damped by beta 1.01, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Sicagen India Limited that is -5.8 % per year a year over ten years, using the same discount rate (12.4 %) and the same formula as our fair value.
How much growth has Sicagen India Limited (533014) delivered so far?
Over the past 5 years revenue at Sicagen India Limited grew +12.4 % a year. The price currently implies -5.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Sicagen India Limited (533014) growing?
The median revenue growth in the sector is +7.3 % a year. That is the yardstick for the growth priced into Sicagen India Limited (-5.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Sicagen India Limited (533014)?
The free-cash-flow yield on the price is 18.57 %: that much free cash flow Sicagen India Limited produces per unit of market value. When it exceeds the discount rate of our models (12.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Sicagen India Limited (533014)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sicagen India Limited it is ₹92.58 per share (as of Oct 2, 2026), against a price of ₹51.45. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Sicagen India Limited stock overvalued or undervalued in 2026?
As of Oct 2, 2026, 533014 trades below its calculated fair value: price ₹51.45, fair value ₹92.58, a gap of about +80% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 533014?
No. The price is what the market pays today (₹51.45); the fair value is what the company's own numbers justify (₹92.58). For Sicagen India Limited the two are ₹41.13 per share apart. That gap is exactly why we show both numbers side by side.
How much is Sicagen India Limited worth?
The market values Sicagen India Limited at about ₹434M (market capitalisation, as of Oct 2, 2026). Per share that is ₹51.45; our models calculate a fair value of ₹92.58 per share.
What do the bullish and bearish scenarios say about 533014?
Our models span a range for Sicagen India Limited: cautious scenario ₹61.97, base ₹92.58, optimistic ₹119.87 per share (as of Oct 2, 2026, price ₹51.45). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 533014?
Sicagen India Limited trades at a price-to-earnings ratio of 12.8 (as of Oct 2, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹92.58 is built from several models across several years.
How far is 533014 from its 52-week high?
Sicagen India Limited trades at ₹51.45, about 26% below its 52-week high of ₹69.10 and 20% above the low of ₹42.78 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹92.58 is for.
Which stocks are comparable to Sicagen India Limited?
From the same area (Industrial Goods) we also value Pacific Industries Limited, Keerthi Industries Limited, Inani Marbles and Industries Limited, SOLIDSTON, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sicagen India Limited stock attractive at the current price?
The data as of Oct 2, 2026: price ₹51.45, calculated fair value ₹92.58 (+80%), Quality Score 62/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 533014 calculated?
We run Sicagen India Limited through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹92.58, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Sicagen India Limited currently trades 44 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sicagen India Limited (533014)?
The closing price on Oct 1, 2026 was ₹51.45. Our model-based fair value is ₹92.58, about +80% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sicagen India Limited right now?
The price is below even our cautious bear case (₹61.97). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (62/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (₹61.97 to ₹119.87) leaves room in how you read the outcome.
Key figures of Sicagen India Limited
How large is the market capitalisation of Sicagen India Limited (533014)?
The market capitalisation of Sicagen India Limited is ₹434M (≈ $4.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Sicagen India Limited (533014)?
The price-to-sales ratio of Sicagen India Limited is 0.24 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Sicagen India Limited (533014)?
Earnings per share at Sicagen India Limited are ₹1.09 (price ÷ EPS = P/E 12.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Sicagen India Limited (533014)?
The dividend yield of Sicagen India Limited is 1.9% (payout 91.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Sicagen India Limited (533014)?
The net margin of Sicagen India Limited is 1.9% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Sicagen India Limited (533014)?
On an EBIT basis the return on assets of Sicagen India Limited is 3.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sicagen India Limited (533014)?
The operating margin of Sicagen India Limited is −0.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sicagen India Limited (533014)?
Revenue at Sicagen India Limited is growing −66.6% versus a year earlier (3y avg +2.8%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Sicagen India Limited (533014) carry?
The net debt of Sicagen India Limited is ₹1.2B (fiscal year 2026, ≈ 3.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Sicagen India Limited in the live analysis
One click puts Sicagen India Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.